Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings
About Jinyu Bio-Technology Co.,Ltd.
Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 金宇生物技术股份有限公司关于拟回购注销2023年员工持股计划部分股票的公告 | 2025-05-28 | Chinese | |
| 金宇生物技术股份有限公司关于回购注销部分股票（暨减少注册资本）通知债权人的公告 | 2025-05-28 | Chinese | |
| 金宇生物技术股份有限公司关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-05-28 | Chinese | |
| 金宇生物技术股份有限公司第十二届董事会第一次会议决议公告 | 2025-05-28 | Chinese | |
| 金宇生物技术股份有限公司2024年年度股东大会决议公告 | 2025-05-28 | Chinese | |
| 金宇生物技术股份有限公司信息披露暂缓与豁免制度 | 2025-05-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40526096 | 金宇生物技术股份有限公司关于拟回购注销2023年员工持股计划部分股票的公告 | 2025-05-28 | Chinese | ||
| 40526073 | 金宇生物技术股份有限公司关于回购注销部分股票（暨减少注册资本）通知债权人的公告 | 2025-05-28 | Chinese | ||
| 40526056 | 金宇生物技术股份有限公司关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-05-28 | Chinese | ||
| 40526048 | 金宇生物技术股份有限公司第十二届董事会第一次会议决议公告 | 2025-05-28 | Chinese | ||
| 40526042 | 金宇生物技术股份有限公司2024年年度股东大会决议公告 | 2025-05-28 | Chinese | ||
| 40526025 | 金宇生物技术股份有限公司信息披露暂缓与豁免制度 | 2025-05-28 | Chinese | ||
| 40526018 | 金宇生物技术股份有限公司2024年年度股东大会法律意见书 | 2025-05-28 | Chinese | ||
| 40526005 | 金宇生物技术股份有限公司关于召开2024年度暨2025年第一季度业绩说明会的公告 | 2025-05-19 | Chinese | ||
| 40525996 | 金宇生物技术股份有限公司关于召开2024年年度股东大会的通知 | 2025-05-06 | Chinese | ||
| 40525981 | 金宇生物技术股份有限公司关于以集中竞价交易方式回购公司股份的进展公告 | 2025-05-06 | Chinese | ||
| 40525971 | 生物股份2024年年度股东大会会议资料 | 2025-05-06 | Chinese | ||
| 40525944 | 金宇生物技术股份有限公司关于延长公司向特定对象发行股票股东大会决议有效期和相关授权有效期的公告 | 2025-04-24 | Chinese | ||
| 40525936 | 审计报告 | 2025-04-24 | Chinese | ||
| 40525766 | 金宇生物技术股份有限公司关于续聘会计师事务所的公告 | 2025-04-24 | Chinese | ||
| 40525752 | 金宇生物技术股份有限公司章程（2025年4月修订） | 2025-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jinyu Bio-Technology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56561/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56561 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56561 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56561 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56561}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jinyu Bio-Technology Co.,Ltd. (id: 56561)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.